Elanco opens dedicated manufacturing facility for autogenous poultry vaccines in Winslow, Maine

Elanco officially opened its new autogenous poultry vaccine manufacturing facility in Winslow, Maine, on the afternoon of Wednesday, May 3, 2017.
calendar icon 3 August 2017
clock icon 3 minute read

Pictured: Milson Gondim (left), D.V.M., Ph.D., VP of Vaccine Operations Manufacturing, and Tim Hopson (right), Senior District Sales Manager, cut the ribbon for the opening of the new autogenous vaccine facility in Winslow, Maine.

The first of its kind for Elanco and the poultry industry, this new state-of-the-art facility is dedicated solely to manufacturing customized inactivated vaccines for the poultry industry. These vaccines will assist in providing solutions to unique disease challenges that cannot be addressed with commercially available vaccines.

“Elanco autogenous vaccines are different than commercial vaccines,” explains Milson Gondim D.V.M., Ph.D., and Vice President of Vaccine Operations Manufacturing for Elanco. “We manufacture these vaccines using flock-specific serotypes not found in commercial vaccines, which gives us the ability to offer poultry producers customized solutions to meet the needs of their specific operation.”

Providing customers with solutions to meet their needs

Pictured: Grace McArdle (center), Site Head in Winslow, gives opening remarks with Tim Hopson (left) and Dr. Milson Gondim (right).

According to Tim Hopson, Elanco Poultry Senior District Sales Manager, the new dedicated autogenous facility reflects Elanco’s on-going commitment to meeting customers’ needs long-term.

“The poultry industry needs solutions that go beyond one-size-fits-all,” says Hopson. “The new facility here in Winslow reflects our commitment to providing our customers with the solutions they need to be productive, sustainable and profitable for years to come.”

In addition to autogenous vaccine production, the Winslow facility is also the only location in the U.S. that produces commercial live and inactivated poultry vaccines for Elanco.

“So whether our customers require a commercial vaccine or one that is customized, this new facility will enhance Elanco’s ability to meet their needs,” says Gondim.

Review our autogenous vaccine FAQ sheet or talk to an Elanco sales representative to learn more.

**The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions.**

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.